Formulary Search
Search Results : Anxiety (Promethazine hydrochloride - Anxiety)
Show Icon and Status Keys
- Oral solution
- Tablets
Off-label use.
Anticholinergic burden score of 3. Consider affect, particularly if used with other anticholinergic drugs.
If using to aid sleep ensure sleep hygenie is provided or referral to sleep CBTi. This can be accessed if patient is under mental health services
- Oral solution
- Tablets
For short term use only
Do not offer a benzodiazepine for the treatment of any anxiety disorder in primary or secondary care except as a short-term measure (2-4 weeks) during crises. Follow the advice in the BNF on the use of a benzodiazepine in this context.
Avoid in the elderly
Beware of MHRA advice on coprescribing of benzodiazepines and opioid and risk of death.
- Injection
For short term use only
Do not offer a benzodiazepine for the treatment of any anxiety disorder in primary or secondary care except as a short-term measure (2-4 weeks) during crises. Follow the advice in the BNF on the use of a benzodiazepine in this context.
Avoid in the elderly
Beware of MHRA advice on coprescribing of benzodiazepines and opioid and risk of death.
For severe acute anxiety
- Tablets
For short term use only
Do not offer a benzodiazepine for the treatment of any anxiety disorder in primary or secondary care except as a short-term measure (2-4 weeks) during crisis. Follow the advice in the BNF on the use of a benzodiazepine in this context.
Avoid in the elderly
Beware of MHRA advice on coprescribing of benzodiazepines and opioid and risk of death
- Tablets
Off-label use. Initiation in Primary Care on request from the Mental Health specialist team.
Do not offer a benzodiazepine for the treatment of anxiety disorder in primary or secondary care except as a short-term measure (2-4 weeks) during crises. Follow the advice in the BNF.
Avoid in the elderly.
Beware of MHRA advice on coprescribing of benzodiazepines and opioid and risk of death.
Care with prescribing / dispensing due to similar drug names (cloNazepam , cloBazam)
- Tablets
Initiation in Primary Care on request from the Mental Health specialist team.
Consider use where clinically relevant liver impairment - oxazepam is less significantly metabolised by the liver than other benzodiazepines.
Do not offer a benzodiazepine for the treatment of anxiety disorder in primary or secondary care except as a short-term measure (2-4 weeks) during crisis. Follow the advice in the BNF.
Avoid in the elderly.
Beware of MHRA advice on coprescribing of benzodiazepines and opioid and risk of death.
Not prescribable in the NHS Primary Care.
- Capsules
See PAD page (click on drug name) for information and advice relating to the risks of prescribing propranolol for patients with anxiety.